Skip to main content
Mantapex
FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)
FDA decision on Ulixacaltamide on or before January 29, 2027Economics
Kalshi Active 1 markets Mutually Exclusive·73¢ What will the FDA's decision be on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027?·$0 Total Volume·-- Liquidity·-- OI
3mo·Feb 6, 2027

Track your prediction positions

Connect your Kalshi account to track your contracts, P&L, and settlements.

What will the FDA's decision be on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027?
Yes 73%
No 27%
$0 Vol
No chart data available

If the FDA's decision on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027 is a full approval or an accelerated approval, the market resolves to Yes.

Series

KXULIXACALTAMIDE
View Full Series

Track Your Bets on Kalshi — and Everything Else

Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted